Technical Analysis for DOVA - Dova Pharmaceuticals, Inc.

Grade Last Price % Change Price Change
grade F 19.42 -4.19% -0.85
DOVA closed down 4.19 percent on Monday, October 15, 2018, on 72 percent of normal volume. The bears made the stock sink to a new 52-week low. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.

Trend Table & Recent Signals
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Down
See historical DOVA trend table...

Date Alert Name Type % Chg
Oct 15 New 52 Week Closing Low Bearish 0.00%
Oct 15 New 52 Week Low Weakness 0.00%
Oct 15 Multiple of Ten Bearish Other 0.00%
Oct 15 Wide Bands Range Expansion 0.00%
Oct 15 Oversold Stochastic Weakness 0.00%
Oct 12 Multiple of Ten Bullish Other -4.19%
Oct 12 Wide Bands Range Expansion -4.19%
Oct 12 Oversold Stochastic Weakness -4.19%
Oct 11 New 52 Week Closing Low Bearish -2.02%
Oct 11 Multiple of Ten Bearish Other -2.02%

Older signals for DOVA ...

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:
Profile
Dova Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on acquiring, developing and commercializing drug candidates. The Company’s initial focus is on thrombocytopenia, a disorder characterized by a low blood platelet count. The Company is developing avatrombopag for treatment of thrombocytopenia in patients with chronic liver disease (CLD). The Company’s product candidate, avatrombopag is an orally administered thrombopoietin receptor agonist, or TPO-RA. The Company has completed pivotal Phase 3 clinical trials that evaluated avatrombopag for the treatment of thrombocytopenia in patients with CLD. The Company has not generated any revenue.
Is DOVA a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 0 bullish, 4 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 37.0
52 Week Low 19.25
Average Volume 187,391
200-Day Moving Average 26.6054
50-Day Moving Average 22.8584
20-Day Moving Average 21.6595
10-Day Moving Average 20.231
Average True Range 1.1097
ADX 30.86
+DI 10.4281
-DI 25.2018
Chandelier Exit (Long, 3 ATRs ) 21.7609
Chandelier Exit (Short, 3 ATRs ) 22.5791
Upper Bollinger Band 25.2206
Lower Bollinger Band 18.0984
Percent B (%b) 0.19
BandWidth 32.882569
MACD Line -1.0583
MACD Signal Line -0.9168
MACD Histogram -0.1415
Fundamentals Value
Market Cap 498.16 Million
Num Shares 25.7 Million
EPS -2.09
Price-to-Earnings (P/E) Ratio -9.29
Price-to-Sales 0.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 21.21
Resistance 3 (R3) 21.35 20.89 20.91
Resistance 2 (R2) 20.89 20.44 20.82 20.81
Resistance 1 (R1) 20.16 20.16 19.93 20.02 20.71
Pivot Point 19.70 19.70 19.59 19.63 19.70
Support 1 (S1) 18.97 19.25 18.74 18.83 18.13
Support 2 (S2) 18.51 18.97 18.44 18.03
Support 3 (S3) 17.78 18.51 17.93
Support 4 (S4) 17.64